Marathon Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.18M Sell
25,288
-898
-3% -$209K 1.39% 22
2025
Q4
$5.42M Sell
26,186
-2,550
-9% -$504K 1.17% 29
2025
Q3
$5.33M Sell
28,736
-473
-2% -$81K 1.22% 26
2025
Q2
$4.46M Sell
29,209
-213
-0.7% -$32.7K 1.14% 28
2025
Q1
$4.88M Sell
29,422
-491
-2% -$76.8K 1.3% 23
2024
Q4
$4.33M Buy
29,913
+214
+0.7% +$33.2K 1.08% 26
2024
Q3
$4.81M Buy
29,699
+31
+0.1% +$4.94K 1.17% 22
2024
Q2
$4.34M Buy
29,668
+940
+3% +$140K 1.11% 21
2024
Q1
$4.54M Buy
28,728
+168
+0.6% +$26.7K 1.08% 26
2023
Q4
$4.48M Buy
28,560
+176
+0.6% +$27K 1.13% 24
2023
Q3
$4.42M Sell
28,384
-7,590
-21% -$1.25M 1.11% 24
2023
Q2
$5.95M Sell
35,974
-379
-1% -$61.2K 1.47% 19
2023
Q1
$5.63M Sell
36,353
-572
-2% -$92.4K 1.39% 16
2022
Q4
$6.52M Sell
36,925
-16
-0% -$2.76K 1.8% 11
2022
Q3
$6.04M Buy
36,941
+10,542
+40% +$1.78M 1.72% 11
2022
Q2
$4.69M Sell
26,399
-73
-0.3% -$13K 1.51% 9
2022
Q1
$4.69M Sell
26,472
-23
-0.1% -$3.91K 1.35% 17
2021
Q4
$4.53M Sell
26,495
-769
-3% -$126K 1.06% 17
2021
Q3
$4.4M Buy
27,264
+1,200
+5% +$205K 1% 17
2021
Q2
$4.29M Sell
26,064
-423
-2% -$70K 0.99% 16
2021
Q1
$4.35M Buy
26,487
+922
+4% +$149K 1.15% 15
2020
Q4
$4.02M Sell
25,565
-475
-2% -$70.1K 1.19% 14
2020
Q3
$3.88M Sell
26,040
-1,791
-6% -$265K 1.41% 8
2020
Q2
$3.91M Sell
27,831
-21
-0.1% -$3.06K 1.5% 8
2020
Q1
$3.65M Sell
27,852
-1,193
-4% -$169K 1.68% 4
2019
Q4
$4.24M Buy
29,045
+6,640
+30% +$901K 1.44% 5
2019
Q3
$2.9M Sell
22,405
-298
-1% -$39.3K 1.17% 8
2019
Q2
$3.16M Buy
22,703
+242
+1% +$33.5K 1.29% 7
2019
Q1
$3.14M Sell
22,461
-363
-2% -$48.6K 1.4% 5
2018
Q4
$2.94M Sell
22,824
-1,021
-4% -$142K 1.46% 3
2018
Q3
$3.29M Sell
23,845
-474
-2% -$63K 1.28% 6
2018
Q2
$2.95M Sell
24,319
-1,075
-4% -$134K 1.11% 9
2018
Q1
$3.25M Sell
25,394
-802
-3% -$108K 1.27% 5
2017
Q4
$3.66M Buy
26,196
+1,339
+5% +$187K 1.43% 7
2017
Q3
$3.23M Sell
24,857
-443
-2% -$58.7K 1.36% 10
2017
Q2
$3.35M Sell
25,300
-686
-3% -$87.5K 1.58% 8
2017
Q1
$3.24M Sell
25,986
-274
-1% -$32.7K 1.6% 9
2016
Q4
$3.02M Sell
26,260
-523
-2% -$60.4K 1.44% 8
2016
Q3
$3.16M Buy
26,783
+1,702
+7% +$206K 1.57% 7
2016
Q2
$3.04M Sell
25,081
-98
-0.4% -$11.1K 1.56% 8
2016
Q1
$2.72M Buy
25,179
+76
+0.3% +$7.87K 1.41% 6
2015
Q4
$2.58M Sell
25,103
-648
-3% -$65.2K 1.37% 8
2015
Q3
$2.4M Sell
25,751
-673
-3% -$65.1K 1.22% 11
2015
Q2
$2.58M Sell
26,424
-538
-2% -$53.9K 1.19% 14
2015
Q1
$2.71M Sell
26,962
-218
-0.8% -$22.2K 1.2% 14
2014
Q4
$2.84M Sell
27,180
-999
-4% -$105K 2.62% 13
2014
Q3
$3M Sell
28,179
-1,017
-3% -$105K 2.71% 12
2014
Q2
$3.06M Sell
29,196
-424
-1% -$42.9K 2.46% 15
2014
Q1
$2.91M Sell
29,620
-753
-2% -$69.8K 2.19% 15
2013
Q4
$2.78M Sell
30,373
-113
-0.4% -$10.4K 2.01% 16
2013
Q3
$2.64M Sell
30,486
-169
-0.6% -$15.2K 2.27% 16
2013
Q2
$2.63M Buy
+30,655
New +$2.6M 2.25% 17

Other funds holding JNJ

Marathon Capital Management's JNJ Position: Q1 2026 in Review

Marathon Capital Management reduced its Johnson & Johnson (JNJ) stake by 3.4% in Q1 2026, selling an estimated $209K and leaving 25,288 shares worth $6.18M. The position accounts for 1.39% of the portfolio, ranked #22.

Marathon Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.52M in Q4 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Marathon Capital Management held 25,288 shares of Johnson & Johnson worth $6.18M as of Q1 2026.
  • Marathon Capital Management sold 898 Johnson & Johnson shares in Q1 2026, an estimated $209K.
  • Johnson & Johnson made up 1.39% of Marathon Capital Management's portfolio in Q1 2026, its #22 holding.
  • Marathon Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Marathon Capital Management's Johnson & Johnson position peaked at $6.52M in Q4 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Marathon Capital Management's 13F filing for Q1 2026, filed 14 May 2026.